Increased signal intensities in different brain regions presumably caused by linear and macrocyclic gadolinium-based contrast agents (GBCAs) could be an indication that gadolinium accumulation is more widespread than previously thought, according to a study presented on Wednesday at RSNA 2018. By Wayne Forrest, AuntMinnie.com staff writer
GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.